|
Genetic Testing – 27 total policies
|
Coverage |
Re-review |
07/01/2023 |
Covered for some indications; investigative and therefore not covered for all other indications
|
Changes reflect updated and validated genetic testing clinical criteria by Concert Genetics, an industry-leader in genetic testing technology assessment and policy development.
- Changes to coverage determinations are policy dependent.
- Refer to specific coverage policies for further information.
|
|
Intravascular Shockwave Lithotripsy for Treatment of Coronary Artery Disease |
Coverage |
New |
07/17/2023 |
Investigative and therefore not covered |
Investigative: Intravascular shockwave lithotripsy for treatment of coronary artery disease. Reliable evidence does not permit conclusions concerning its effectiveness. |
|
Radiofrequency Ablation (RFA) of Uterine Fibroids |
Coverage |
New
|
07/17/2023 |
Covered for some indications; investigative and therefore not covered for all other indications
|
Not investigative: Laparoscopic RFA of uterine fibroids
Investigative: Transcervical RFA of uterine fibroids. Reliable evidence does not permit conclusions concerning its effectiveness.
|